RNA interference-mediated simultaneous down-regulation of urokinase-type plasminogen activator receptor and cathepsin B induces caspase-8-mediated apoptosis in SNB19 human glioma cells

被引:31
作者
Gondi, Christopher S.
Kandhukuri, Neelima
Kondraganti, Shakuntala
Gujrati, Meena
Olivero, William C.
Dinh, Dzung H.
Rao, Jasti S.
机构
[1] Univ Illinois, Dept Biomed & Therapeut Sci, Program Canc Biol, Coll Med, Peoria, IL 61605 USA
[2] Univ Illinois, Coll Med, Dept Pathol, Peoria, IL 61605 USA
[3] Univ Illinois, Coll Med, Dept Neurosurg, Peoria, IL 61605 USA
关键词
D O I
10.1158/1535-7163.MCT-05-0531
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The invasive character of gliomas depends on proteolytic cleavage of the surrounding extracellular matrix. Cathepsin B and urokinase-type plasminogen activator receptor (uPAR) together are known to be overexpressed in gliomas and, as such, are attractive targets for gene therapy. In the present study, we used plasmid constructs to induce the RNA interference (RNAi)-mediated down-regulation of uPAR and cathepsin B in SNB19 human glioma cells. We observed that the simultaneous down-regulation of uPAR and cathepsin B induces the up-regulation of proapoptotic genes and initiates a collapse in mitochondrial Delta psi. Cathepsin B and uPAR down-regulated cells showed increases in the expression of activated caspase-8 and DFF40/caspase-activated DNase. Nuclear translocation of AIF and Fas ligand translocation to the cell membrane were also observed. Ki67 and X-linked inhibitor of apoptosis protein levels decreased, thereby indicating apoptosis. These results suggest the involvement of uPAR-cathepsin B complex on the cell surface and its role in maintaining the viability of SNB19 glioma cells. In conclusion, RNAi-mediated down-regulation of uPAR and cathepsin B initiates a partial extrinsic apoptotic cascade accompanied by the nuclear translocation of AIF.
引用
收藏
页码:3197 / 3208
页数:12
相关论文
共 38 条
[1]   EXPRESSION OF 72-KDA TYPE-IV COLLAGENASE AND INVASION ACTIVITY OF HUMAN GLIOMA-CELLS [J].
ABE, T ;
MORI, T ;
KOHNO, K ;
SEIKI, M ;
HAYAKAWA, T ;
WELGUS, HG ;
HORI, S ;
KUWANO, M .
CLINICAL & EXPERIMENTAL METASTASIS, 1994, 12 (04) :296-304
[2]   Molecular proximity of seprase and the urokinase-type plasminogen activator receptor on malignant melanoma cell membranes:: dependence on β1 integrins and the cytoskeleton [J].
Artym, VV ;
Kindzelskii, AL ;
Chen, WT ;
Petty, HR .
CARCINOGENESIS, 2002, 23 (10) :1593-1601
[3]   Cell-surface cathepsin B: Understanding its functional significance [J].
Cavallo-Medved, D ;
Sloane, BF .
CELL SURFACE PROTEASES, 2003, 54 :313-341
[4]   The BCL2 family: Regulators of the cellular life-or-death switch [J].
Cory, S ;
Adams, JM .
NATURE REVIEWS CANCER, 2002, 2 (09) :647-656
[5]   Mice lacking TNFα receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody [J].
Costelli, P ;
Aoki, P ;
Zingaro, B ;
Carbó, N ;
Reffo, P ;
Lopez-Soriano, FJ ;
Bonelli, G ;
Argilés, JM ;
Baccino, FM .
CELL DEATH AND DIFFERENTIATION, 2003, 10 (09) :997-1004
[6]   Role of AIF in caspase-dependent and caspase-independent cell death [J].
Cregan, SP ;
Dawson, VL ;
Slack, RS .
ONCOGENE, 2004, 23 (16) :2785-2796
[7]   Cathepsin B and glioma invasion [J].
Demchik, LL ;
Sameni, M ;
Nelson, K ;
Mikkelsen, T ;
Sloane, BF .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 1999, 17 (5-6) :483-494
[8]   The Jak/Stat pathway and urokinase receptor signaling inhuman aortic vascular smooth muscle cells [J].
Dumler, I ;
Weis, A ;
Mayboroda, OA ;
Maasch, C ;
Jerke, U ;
Haller, H ;
Gulba, DC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :315-321
[9]  
GLADSON CL, 1995, AM J PATHOL, V146, P1150
[10]   Inhibition of in vivo tumorigenicity and invasiveness of a human glioblastoma cell line transfected with antisense uPAR vectors [J].
Go, Y ;
Chintala, SK ;
Mohanam, S ;
Gokaslan, Z ;
Venkaiah, B ;
Bjerkvig, R ;
Oka, K ;
Nicolson, GL ;
Sawaya, R ;
Rao, JS .
CLINICAL & EXPERIMENTAL METASTASIS, 1997, 15 (04) :440-446